- Home
- GHRS vs AEVA Comparison
GHRS vs AEVA Comparison
Compare GHRS & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- AEVA
- Stock Information
- Founded
- GHRS 2018
- AEVA 2019
- Country
- GHRS Ireland
- AEVA United States
- Employees
- GHRS N/A
- AEVA N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- AEVA Auto Parts:O.E.M.
- Sector
- GHRS Health Care
- AEVA Consumer Discretionary
- Exchange
- GHRS Nasdaq
- AEVA Nasdaq
- Market Cap
- GHRS 874.0M
- AEVA 737.9M
- IPO Year
- GHRS 2021
- AEVA N/A
- Fundamental
- Price
- GHRS $12.22
- AEVA $15.45
- Analyst Decision
- GHRS Strong Buy
- AEVA Strong Buy
- Analyst Count
- GHRS 8
- AEVA 5
- Target Price
- GHRS $30.63
- AEVA $20.80
- AVG Volume (30 Days)
- GHRS 183.0K
- AEVA 2.7M
- Earning Date
- GHRS 08-07-2025
- AEVA 11-05-2025
- Dividend Yield
- GHRS N/A
- AEVA N/A
- EPS Growth
- GHRS N/A
- AEVA N/A
- EPS
- GHRS N/A
- AEVA N/A
- Revenue
- GHRS N/A
- AEVA $13,825,000.00
- Revenue This Year
- GHRS N/A
- AEVA $110.19
- Revenue Next Year
- GHRS N/A
- AEVA $96.22
- P/E Ratio
- GHRS N/A
- AEVA N/A
- Revenue Growth
- GHRS N/A
- AEVA 111.39
- 52 Week Low
- GHRS $6.00
- AEVA $2.38
- 52 Week High
- GHRS $20.50
- AEVA $38.80
- Technical
- Relative Strength Index (RSI)
- GHRS 37.28
- AEVA 50.16
- Support Level
- GHRS $13.71
- AEVA $12.86
- Resistance Level
- GHRS $14.59
- AEVA $16.10
- Average True Range (ATR)
- GHRS 0.73
- AEVA 1.22
- MACD
- GHRS -0.09
- AEVA 0.49
- Stochastic Oscillator
- GHRS 4.62
- AEVA 61.17
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.